Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
about
Discerning the clinical relevance of biomarkers in early stage breast cancer.Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis.A peek into epidemiology, screening, management of breast cancer in developing countries: Experience from two regional cancer centers in India.Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients.
P2860
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adjuvant doxorubicin and cyclo ...... ode positive breast carcinoma.
@ast
Adjuvant doxorubicin and cyclo ...... ode positive breast carcinoma.
@en
type
label
Adjuvant doxorubicin and cyclo ...... ode positive breast carcinoma.
@ast
Adjuvant doxorubicin and cyclo ...... ode positive breast carcinoma.
@en
prefLabel
Adjuvant doxorubicin and cyclo ...... ode positive breast carcinoma.
@ast
Adjuvant doxorubicin and cyclo ...... ode positive breast carcinoma.
@en
P2093
P2860
P1433
P1476
Adjuvant doxorubicin and cyclo ...... ode positive breast carcinoma.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20001215)89:12<2521::AID-CNCR2>3.0.CO;2-F
P407
P577
2000-12-01T00:00:00Z